ALLYSTA PHARMACEUTICALS INC has a total of 29 patent applications. It increased the IP activity by 1400.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are ONCOPEP INC, REMEGEN LTD and AMAL THERAPEUTICS SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | EPO (European Patent Office) | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Israel | 2 | |
#9 | Singapore | 2 | |
#10 | Hong Kong | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Hsu Henry | 23 |
#2 | Otvos Laszlo | 7 |
#3 | Ward Kevin L | 3 |
#4 | Barman Shikha P | 3 |
#5 | Chen Yugang | 3 |
#6 | Henry Hsu | 1 |
Publication | Filing date | Title |
---|---|---|
US2020129585A1 | Adiponectin peptidomimetics formulations | |
AU2018231180A1 | Peptides for dry eye disease | |
EP3288577A1 | Adiponectin peptidomimetics for treating ocular disorders |